KBLB (Kraig Biocraft Laboratories) ROIC %: -146.94% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KBLB Kraig Biocraft Laboratories Inc KBLB
30 GF Score
Price $0.10
! 2 Warning Signs
View Full Analysis

What is Kraig Biocraft Laboratories ROIC %?

Kraig Biocraft Laboratories KBLB -0.34% 30 ROIC % is -146.94% as of Mar. 2026. GuruFocus rates KBLB with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Kraig Biocraft Laboratories's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2026 was -146.94%.

As of today (2026-07-14), Kraig Biocraft Laboratories's WACC % is 17.33%. Kraig Biocraft Laboratories's ROIC % is -154.14% (calculated using TTM income statement data). Kraig Biocraft Laboratories earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Kraig Biocraft Laboratories  (OTCPK:KBLB) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Kraig Biocraft Laboratories's WACC % is 17.33%. Kraig Biocraft Laboratories's ROIC % is -154.14% (calculated using TTM income statement data). Kraig Biocraft Laboratories earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Kraig Biocraft Laboratories ROIC % Related Terms


Kraig Biocraft Laboratories ROIC % Historical Data

* Premium members only.

The historical data trend for Kraig Biocraft Laboratories's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kraig Biocraft Laboratories ROIC % Chart

Kraig Biocraft Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -102.95 -80.65 -111.47 -128.61 -144.54

Kraig Biocraft Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -93.85 -103.97 -242.33 -126.26 -146.94

KBLB vs AMTX, FSI, NTIC: ROIC % Comparison

For the Specialty Chemicals subindustry, Kraig Biocraft Laboratories's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kraig Biocraft Laboratories ROIC % vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Kraig Biocraft Laboratories's ROIC % distribution charts can be found below:

* The bar in red indicates where Kraig Biocraft Laboratories's ROIC % falls into.


KBLB
30GF Score
Kraig Biocraft Laboratories Inc KBLB
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kraig Biocraft Laboratories ROIC % Calculation

Kraig Biocraft Laboratories's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=-3.375 * ( 1 - 0% )/( (2.429 + 2.241)/ 2 )
=-3.375/2.335
=-144.54 %

where

Kraig Biocraft Laboratories's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2026 is calculated as:

ROIC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=-3.304 * ( 1 - 0% )/( (2.241 + 2.256)/ 2 )
=-3.304/2.2485
=-146.94 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of -146.94% mean?
Kraig Biocraft Laboratories (KBLB) has a ROIC % of -146.94% as of Mar. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Kraig Biocraft Laboratories and its competitors.
Is Kraig Biocraft Laboratories' ROIC % too high?
Kraig Biocraft Laboratories' current ROIC % is -146.94%. Overall, Kraig Biocraft Laboratories has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Kraig Biocraft Laboratories' ROIC % compare to AMTX and FSI?
Kraig Biocraft Laboratories' ROIC % of -146.94% can be compared against companies in the Chemicals industry. The industry median ROIC % is 4.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Chemicals company?
The median ROIC % among Chemicals companies is 4.48, based on 1,577 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Kraig Biocraft Laboratories and its competitors. For the Chemicals industry, the median ROIC % is 4.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kraig Biocraft Laboratories's current ROIC % is -146.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kraig Biocraft Laboratories stock overvalued right now?
Kraig Biocraft Laboratories (KBLB) has a current ROIC % of -146.94%. The current ROIC % is -146.94%. Kraig Biocraft Laboratories' overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Kraig Biocraft Laboratories (KBLB), the current ROIC % is -146.94% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kraig Biocraft Laboratories Business Description

Address 2723 South State Street, Suite 150, Ann Arbor, MI, USA, 48104
Kraig Biocraft Laboratories Inc is engaged in the development of high-strength fiber using recombinant DNA technology mainly for commercial applications. It uses genetic engineering technologies to develop fibers with greater strength, resiliency, and flexibility for use in its target markets, namely the textile, specialty fiber, and technical textile industries. Its products include Monster Silk, which incorporates the natural elasticity of spider silk to make a silk fiber that is more flexible than conventional silk fibers and textiles; Dragon Silk, which combines the elasticity of Monster Silk with additional high-strength elements of native spider silk; Spydasilk; and Spydra.
30GF Score

Get the complete analysis for KBLB

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price